Back to Search
Start Over
Epilogue: New Drugs for Neglected Diseases.
- Source :
-
Cambridge Quarterly of Healthcare Ethics . 04/01/2011, Vol. 20 Issue 2, p329-334. 6p. - Publication Year :
- 2011
-
Abstract
- In a widely cited 2003 article, DiMasi, Hansen, and Grabowski estimated the cost of pharmaceutical research and development to be $1.1 billion (year 2000 U.S. dollars) per new medicine coming onto the market in 2001. They also estimate that this cost is going up at a real (inflation-adjusted) rate of 7.4% annually. According to these estimates, the innovation cost per new medicine today is about $2.1 billion (year 2000 U.S. dollars) or $2.65 billion (year 2010 U.S. dollars). [ABSTRACT FROM PUBLISHER]
Details
- Language :
- English
- ISSN :
- 09631801
- Volume :
- 20
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Cambridge Quarterly of Healthcare Ethics
- Publication Type :
- Academic Journal
- Accession number :
- 59665588
- Full Text :
- https://doi.org/10.1017/S0963180110000988